Flexible cannulas safest for akinesia

Article

Flexible cannulas are safest for akinesia and anaesthesia in the latest comparison study on sub-Tenon cannulas.

Flexible cannulas are safest for akinesia and anaesthesia in the latest comparison study on sub-Tenon cannulas.

A team led by Dr Waleed Riad, King Khaled Specialist Eye Hospital, Riyadh, Saudi Arabia, conducted a prospective, blind, randomized comparison between metal posterior, flexible posterior and flexible medium sub-Tenon cannulas forakinesia and anaesthesia.

The investigation included 159 patients who underwent cataract surgery under sub-Tenon block. All patients received a combination of bupivacaine and lidocaine with hyaluronidase.

Patients were divided into three groups. Group 1 received a metal posterior sub-Tenon cannula, group 2 had a flexible posterior sub-Tenon cannula and group 3 had a flexible medium sub-Tenon cannula. The outcome measures included pain during injection, akinesia, anesthesia, and complications.

Two minutes after injection the akinesia score, superior oblique muscle activity, lid movements and pain during injection was significantly lower in group 1. However, after four, six, eight and ten minutes there was no significant difference between cannulas.

Intraoperative pain was low for all groups but chemosis was significantly lower in group 2 and was found to be safer than the rigid cannulas.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.